Forte Biosciences (FBRX) Interest & Investment Income (2016 - 2020)
Forte Biosciences' (FBRX) quarterly Interest & Investment Income came in at $58000.0 in Q1 2020, down 89.28% year-on-year from $541000.0 in Q2 2019, and down 70.56% on a QoQ basis from $197000.0 in Q4 2019.
Forte Biosciences (FBRX) Interest & Investment Income (2016 - 2020) Analysis & Trends
Forte Biosciences (FBRX) has 5 years of Interest & Investment Income data on file, last reported at $58000.0 in Q1 2020.
- On a quarterly basis, Interest & Investment Income fell 89.28% year-over-year to $58000.0 in Q1 2020; TTM through Mar 2020 was $1.1 million, a 38.58% decrease from a year earlier, with the FY2019 full-year figure at $1.6 million, up 1.96% from the prior year.
- Interest & Investment Income for Q1 2020 stood at $58000.0, down from $197000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for FBRX reached as high as $541000.0 in Q1 2019 and fell as low as $37000.0 in Q1 2017.
- Historically, Interest & Investment Income has averaged $233294.1 across 5 years, with a median of $214000.0 in 2017.
- Across the five-year window, Interest & Investment Income soared 751.35% in 2018 and sank 89.28% in 2020, its largest moves.
- Year by year, Interest & Investment Income stood at $45000.0 in 2016, then soared by 435.56% to $241000.0 in 2017, then soared by 85.48% to $447000.0 in 2018, then sank by 55.93% to $197000.0 in 2019, then tumbled by 70.56% to $58000.0 in 2020.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $58000.0 in Q1 2020, $197000.0 in Q4 2019, and $361000.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Forte Biosciences | 1.37 Bn | 1.31 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 58,000.00 |
| Dec 31, 2019 | 197,000.00 |
| Sep 30, 2019 | 361,000.00 |
| Jun 30, 2019 | 465,000.00 |
| Mar 31, 2019 | 541,000.00 |
| Dec 31, 2018 | 447,000.00 |
| Sep 30, 2018 | 441,000.00 |
| Jun 30, 2018 | 331,000.00 |
| Mar 31, 2018 | 315,000.00 |
| Dec 31, 2017 | 241,000.00 |
| Sep 30, 2017 | 214,000.00 |
| Jun 30, 2017 | 103,000.00 |
| Mar 31, 2017 | 37,000.00 |
| Dec 31, 2016 | 45,000.00 |
| Sep 30, 2016 | 53,000.00 |
| Jun 30, 2016 | 56,000.00 |
| Mar 31, 2016 | 61,000.00 |